Thaddeus R. Tolleson

Author

Columbia University Irving Medical Center

Also Known As

Joseph Rossi, T Tolleson, Thaddeus R Tolleson, Thaddeus R. Tolleson, Thaddeus Tolleson

Publications

852

Citations

H-Index

Concepts

All Affiliations

Columbia University Irving Medical Center Clinical Research Institute Stanford University Baim Institute for Clinical Research Beth Israel Deaconess Medical Center

About

Thaddeus R. Tolleson is an author at Columbia University Irving Medical Center specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	540
2	Emergency Medicine	2	2	140
3	Public Health	1	1	34
4	Biomedical Engineering	1	1	20
5	Pharmacology	1	1	20

Thaddeus R. Tolleson

Publications

784

Citations

H-Index

Page 1

	Year	Citations
A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions Martin B. Leon, Laura Mauri, Jeffrey J. Popma, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseTaxus Paclitaxel-eluting StentLumen-apposing Metal StentCardiology	2010	240
Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries Alan C. Yeung, Martin B. Leon, Ash Jain, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseNative Coronary ArteriesDe Novo LesionsCardiology	2011	140
Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes Wayne Batchelor, Thaddeus R. Tolleson, Yao Huang, Circulation	2002	123
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention Thaddeus R. Tolleson, J.Conor O’Shea, John A. Bittl, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionHeparin AnticoagulationCardiovascular DiseaseCoronary Artery Disease	2003	106
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients David E. Kandzari, Ajay J. Kirtane, Stephan Windecker, Circulation Cardiovascular Interventions	2020	65
Successful percutaneous coronary intervention with stent implantation in anomalous right coronary arteries arising from the left sinus of valsalva: A report of two cases Mauricio G. Cohen, Thaddeus R. Tolleson, Robert H. Peter, Catheterization and Cardiovascular Interventions	2001	43
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials) Thaddeus R. Tolleson, L. Kristin Newby, Robert A. Harrington, The American Journal of Cardiology Percutaneous Coronary InterventionThrombosisStent ThrombosisSymphony TrialsCardiovascular Disease	2003	34
Enhanced thrombolysis, reduced coronary reocclusion and limitation of infarct size with liposomal prostaglandin E1in a canine thrombolysis model Steven Feld, George Li, James Amirian, Journal of the American College of Cardiology ThrombopoiesisThrombosisEnhanced ThrombolysisCardiovascular DiseaseBlood Platelet	1994	20
Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; Results from the ESPRIT trial Jean‐Pierre Déry, Mark Campbell, Jasmine Mathias, Catheterization and Cardiovascular Interventions	2007	13

Page 1